Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

CSS announces new licensing agreement

14 Jun 2023 07:42

RNS Number : 6200C
Barkby Group PLC
15 June 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

Barkby Group PLC

 

("Barkby" or the "Company")

 

 

Cambridge Sleep Sciences Announces Bowers & Wilkins Licensing Deal and Partnership Agreement

 

 

Barkby (AIM: BARK) announces that its subsidiary, Cambridge Sleep Sciences, ("CSS") the science-based sleep technology business behind SleepHub®, has signed a new partnership and license agreement with Bowers & Wilkins, part of the consumer audio division of Masimo Inc., the US headquartered global medical technology company. Masimo Consumer Audio owns one of the world's largest portfolios of audio companies, with brands including Bowers & Wilkins, Denon, Marantz, Polk, Definitive Technology, Classe, Heos and Boston Acoustics.

 

The agreement enables the unique SleepEngineTM technology, developed by CSS and used within its SleepHub® product, to be delivered through Bowers & Wilkins Audio's premium products, including the Bowers & Wilkins Zeppelin wireless speaker and Px7 and Px8 wireless headphones. Masimo Consumer Audio will be responsible for marketing and distributing SleepEngineTM. Accessed through the Bowers & Wilkins Music Store, customers will be able to choose from a range of programmes that deliver scientifically developed sounds which retrain the brain to restore natural sleep patterns. 

 

CSS and Bowers & Wilkins will share the revenue generated from the new service. Given the number of users of Bowers & Wilkins products globally, Masimo Consumer Audio and CSS expects the license to generate substantial revenues. The agreement is initially valid until 31 December 2025 and can be renewed for an additional three years by mutual consent.

 

Dr Julian Stone, CEO at CSS said:

"We are delighted to be partnering with Masimo Consumer Audio. This deal shows significant progress in the growth of the CSS business. Following the success of our SleepHub® product, being able to offer our unique SleepEngineTM technology in such high-quality audio products will provide added value to customers and help many to improve their sleep, health and wellbeing. We look forward to working with the Masimo Consumer Audio team to successfully launch this and future technology solutions across their portfolio of products."

 

 

SleepEngine® technology has been developed and refined over more than a decade by a team of researchers, scientists, sound and medical experts. The result is a unique audio solution that helps to retrain the brain to restore healthy natural sleep patterns, a key component for mental, physical, and cognitive wellbeing. SleepEngine® technology offers a unique integration opportunity with existing or new third-party products capable of delivering high quality audio.

 

The incorporation of this technology into premium third-party products, such as those provided by Bowers & Wilkins, marks the next commercial phase for CSS as it continues to grow its Software As A Service business model. The overarching mission of CSS is to improve the quality of life for millions of people through delivering scientifically developed sound solutions.

 

CSS is in discussions on a number of other SleepEngineTM licensing deals and looks forward to updating shareholders.

 

 

- Ends -

For more information

 

Barkby Group plc

Charles Dickson, Executive Chairman

 

c/o Montfort Communications

finnCap Ltd (Nomad and Broker)

Carl Holmes and Simon Hicks (Corporate Finance)

Tim Redfern (ECM)

 

+44 (0)20 7220 0500

Montfort

Olly Scott

Georgia Colkin

 

+44 (0)78 1234 5205

 

 

About Barkby

Barkby is a roadside real estate business focused on building and scaling a high-quality portfolio of modern, ESG-compliant assets. It is in the process of exiting its non-core investments.

 

 

About Cambridge Sleep Sciences Ltd

Cambridge Sleep Sciences Ltd, part of the Life Sciences division of The Barkby Group Plc, develops technology which improves natural sleep. Using the principles of neuroscience and cutting-edge technology to enhance brain activity during sleep, its innovative solutions aim to improve health, wellbeing and enhance quality of life. 

 

The company prides itself on delivering the first neuroscience-based electronic sleep product, SleepHub®, to help improve and facilitate natural sleep. 

 

Find out more at: www.cambridgesleepsciences.com

 

About Masimo Consumer Audio (previously Sound United)

One of the world's largest portfolio audio companies, Masimo Consumer Audio is home to eight legendary audio brands: Bowers & Wilkins, Denon, Marantz, Polk Audio, Definitive Technology, Classé, HEOS, and Boston Acoustics. Each brand boasts its own philosophy and unique approach to bringing sound and home entertainment to life.

 

With over 300 combined years of innovative audio and home solution expertise, Masimo Consumer Audio improves lives by creating distinct and immersive listening experiences for millions of consumers in more than 130 countries.

 

Find out more at: www.masimo.com/consumer-audio/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUSFWEDDEDSEFM
12
Date   Source Headline
27th Oct 20219:05 amRNSSecond Price Monitoring Extn
27th Oct 20219:00 amRNSPrice Monitoring Extension
27th Oct 20217:00 amRNSTrading Statement and Property Acquisition
10th Aug 20217:00 amRNSTrading Statement
16th Jun 20217:00 amRNSNew lease for The Ebrington Arms
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
7th May 20211:48 pmRNSResult of AGM and change of name
30th Apr 20217:00 amRNSInterim Results
15th Apr 20217:00 amRNSCambridge Sleep Sciences signs new partners
9th Apr 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Apr 20217:00 amRNSVerso Biosense signs collaboration agreement
31st Mar 20216:29 pmRNSFinal Results
25th Mar 20217:00 amRNSVerso Biosense signs agreement with hospital
11th Mar 20217:00 amRNSCambridge Sleep Sciences partnership announcement
3rd Mar 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSExchange of Contracts at Malden, Essex
24th Dec 20207:00 amRNSExtension of Warrants
21st Dec 20207:00 amRNSExercise of Warrants and Total Voting Rights
6th Nov 20207:03 amRNSExtension of Reporting Deadline
30th Oct 20207:00 amRNSWorkshop Coffee becomes UK Distributor for MiiR
23rd Oct 20207:00 amRNSCambridge Sleep Sciences Ltd launches 'SleepHub™'
30th Sep 20207:00 amRNSCompany Update and Issue of Equity
17th Sep 20207:00 amRNSNew lease for The Harcourt Arms
10th Aug 20207:00 amRNSPractical Completion of Hastings
3rd Aug 20207:00 amRNSInvestment in VivoPlex Group
22nd Jul 20207:00 amRNSUpdate and CBILS loan
21st Apr 20207:00 amRNSAgreement with Cambridge Sound Technologies
20th Apr 20207:32 amRNSVivoPlex prepares for clinical feasibility study
24th Mar 20202:57 pmRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSConfirmation of Director Appointment
23rd Mar 20207:00 amRNSInterim Results
3rd Mar 20207:00 amRNSProposed acquisition
6th Feb 20207:00 amRNSAppointment of Senior Manager
3rd Feb 20207:00 amRNSAppointment of Chief Financial Officer
17th Jan 20207:00 amRNSExchange of Contracts at Huntingdon
7th Jan 20207:00 amRNSCompletion of Acquisition
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.